Smith & Nephew is a global medical technology company that specializes in the development and manufacturing of innovative products and solutions for healthcare professionals
The company focuses on advanced surgical devices, advanced wound management, and orthopedics, providing cutting-edge technologies to enhance patient outcomes and improve the quality of care. Through its commitment to research and development, Smith & Nephew aims to address the complex needs of healthcare practitioners and their patients, delivering effective and reliable solutions in various medical settings.
Shares of NIO Inc. (NYSENIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has resigned as the Chief Financial Officer for personal and family
Smith & Nephew shares rise as Cevian Capital acquires a 5% stake, aiming to improve operational performance. The medical tech firm faces challenges with declining market cap and mixed revenue growth.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Over the past year, SNN's share price fell about 9.4% from $32.50 to $25.84 as of Thursday’s market close.
Smith & Nephew shakes up executive pay structure, aligning with US standards to curb turnover. Chairman Rupert Soames addresses global talent recruitment challenges and the shift's significance in the competitive med-tech market.
Citigroup raised the price target for LyondellBasell Industries N.V. (NYSELYB) from $104 to $106. Citigroup analyst Patrick Cunningham upgraded the stock from Neutral to Buy. LyondellBasell Industries shares gained 0.4% to close at $93.79 on Tuesday.
U.S. stocks traded mixed, with the Dow Jones dropping around 30 points on Monday. Here are some big stocks recording losses in today’s session. Protagonist Therapeutics, Inc. (NASDAQPTGX) shares dipped 36.4% to $17.60.
Gainers Athersys, Inc. (NASDAQATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 2022.
